Search Results

Press Releases

RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine

December 17, 2024

·

2 min read

Press Releases

RTI Surgical Completes Acquisition of Collagen Solutions

November 4, 2024

·

1 min read

Press Releases

RTI Surgical celebrates expansion of Tutoplast® Tissue Sterilization Process facility

October 31, 2024

·

2 min read

Deals

RTI Surgical Completes Acquisition of Cook Biotech

RTI Surgical, an industry leading contract development and manufacturing organization, serving the regenerative medicine industry, announced that it has completed its previously announced acquisition of Cook Biotech Incorporated.

February 1, 2024

·

3 min read

Press Releases

RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction

November 25, 2024

·

2 min read

Deals

RTI Surgical Announces Agreement to Acquire Cook Biotech from Cook Group

RTI Surgical announced that it has signed a definitive agreement to acquire Cook Biotech Incorporated, a leader in advanced tissue-repair products from biomaterials, headquartered in West Lafayette, Indiana.

January 8, 2024

·

4 min read

Press Releases

RTI Announces its Second Annual Medical Technology Forum Featuring Speakers from NVIDIA, Medtronic, and Asensus Surgical

October 2, 2024

·

2 min read

Press Releases

RTI Surgical appoints Chad Croasdale as Chief Commercial Officer

July 11, 2024

·

2 min read

Deals

Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical

Xtant Medical Holdings, Inc. announced that it has acquired the nanOss production operations from RTI Surgical, Inc., a leading CDMO in regenerative medicine.

October 23, 2023

·

5 min read

FDA

RTI Surgical Inc. Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction

RTI Surgical, a leading global medical device organization, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for a clinical study designed to confirm the safety and effectiveness of Cortiva ® Allograft Dermis in implant-based breast reconstruction.

November 27, 2023

·

2 min read